Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05668351 · ClinicalTrials.gov registry record · NA

Stereotactic Ablative Radiation Therapy for Prostate Cancer

A NA study of Prostate Cancer, sponsored by Medical University of South Carolina.

Active
Registry status
NA
Development phase
42
Enrollment target
1
Study location

NCT05668351 is a NA study of Prostate Cancer that is active but no longer recruiting, run by Medical University of South Carolina. The registered enrollment target is 42 participants, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05668351, a NA study of Prostate Cancer, is active but no longer recruiting, sponsored by Medical University of South Carolina.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
42 participants
Enrollment target
1
Study location

Study Summary

This single arm trial will investigate a novel way to plan and deliver SABR for prostate cancer. Prostate-directed SABR will be high-dose SABR (40 Gy in 5 fractions) with central sparing of the urethra and peripheral sparing of the rectum and pudendal arteries (SUPR-SABR). This study tests the hypothesis that genitourinary (GU) and gastrointestinal (GI) toxicity rates following SUPR-SABR are comparable to (or possibly lower than) historical GU and GI toxicity rates following standard SABR (stSABR) with 36.25 Gy in the treatment of low- and intermediate-risk prostate cancer.

Conditions Studied

Prostate Cancer

Interventions

  • RADIATION SUPR-SABR treatment

Study Locations (1)

South Carolina

  • Medical University of South Carolina Hollings Cancer Center - Charleston

Trial Details

FieldValue
Enrollment Target 42 participants
Start Date 2023-05-12
Est. Completion 2028-01-15
Phase NA

Sponsor

Medical University of South Carolina

755 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05668351

The ClinicalTrials.gov registry entry for NCT05668351 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 42 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (93% lower). The listed sponsor is Medical University of South Carolina, which has 755 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Prostate Cancer appearing as the primary indexed condition, and to 1 intervention - of which SUPR-SABR treatment is the first listed.

NCT05668351 reports 1 study location spanning 1 distinct geographic area - top geographies include South Carolina.

Frequently Asked Questions

What is clinical trial NCT05668351 about?

NCT05668351 is a clinical study titled "Stereotactic Ablative Radiation Therapy for Prostate Cancer". This single arm trial will investigate a novel way to plan and deliver SABR for prostate cancer. Prostate-directed SABR will be high-dose SABR (40 Gy in 5 fractions) with central sparing of the urethra and peripheral sparing of the rectum and pudendal arteries (SUPR-SABR). This study tests the hypot...

What is the current status of trial NCT05668351?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 42 participants. The study started on 2023-05-12. Estimated completion is 2028-01-15.

What conditions does trial NCT05668351 study?

This clinical trial studies the following conditions: Prostate Cancer.

What interventions are being tested in trial NCT05668351?

The interventions under investigation include: SUPR-SABR treatment (RADIATION).

Who is sponsoring clinical trial NCT05668351?

This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05668351 being conducted?

This trial has 1 study location across South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Prostate Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Prostate Cancer

All registered trials for this condition

South Carolina

All trials with a study site in South Carolina

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.